COVID-19
NCCN recommends immunocompromised patients receive a fifth mRNA vaccine.
These are all things that we have lost over the past 2 years in our limited face-to-face interactions and are things that we ...
Patients with hematologic malignancies have a significantly higher rate of composite thrombotic outcomes.
Researchers have discovered that chemotherapy and COVID-19 infection cause neuro-inflammation in similar ways.
The Government Accountability Office says the US Department of Health and Human Services is at high risk of mismanaging a ...
The results of two studies indicate that the mRNA COVID-19 vaccine may have attenuated efficacy in people with CLL.
Researchers sought to discern the effect of COVID-19 countermeasures on treatment outcomes in a patient population receiving ...
Zainab Shahid, MD, FACP, and Shaji K. Kumar, MD ...
Drs. Saad Usumani and Sydney Lu discuss adjusting multiple myeloma treatments to the realities of the COVID-19 pandemic.
A study published in The Lancet Haematology reviewed responses to the first dose of the SARS-CoV-2 vaccine in patients with ...
The guidance is based on expert opinion and current limited data relating to vaccination in patients with active malignancy.
According to new data published in Blood, patients with multiple myeloma (MM) who are hospitalized for COVID-19 infection ...
Patients with Hematologic Cancers Have More Severe Reaction to COVID-19 Than Those With Solid Tumors
The study included a cohort of 1044 adults with cancer who were enrolled in the UK Coronavirus Cancer Monitoring Project.
A study published in Blood identified the following factors as predictive of worse outcomes for patients with multiple ...
Sarah Holstein, MD, PhD, discusses the lack of Black patients with multiple myeloma enrolled in clinical trials.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.